Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudarsan Mandal

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Indian Journal of Tuberculosis|June 27, 2022
Towards building a tuberculosis free worldSudarsan Mandal
Indian Journal of Public Health|June 27, 2024
Hypertension in India: Navigating Challenges and Opportunities within Universal Health CareSudarsan Mandal, Ashish Bhat
BMJ Open|August 29, 2022
Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant/non-responsive multidrug-resistant pulmonary tuberculosis: study protocolChandrasekaran Padmapriyadarsini, Bella Devaleenal, C Ponnuraja, et al.
BMJ Open|July 28, 2022
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020Kathiresan Jeyashree, Jeromie Thangaraj, Kiran Rade, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Indian Journal of Tuberculosis|June 27, 2022
Towards building a tuberculosis free worldSudarsan Mandal
Indian Journal of Public Health|June 27, 2024
Hypertension in India: Navigating Challenges and Opportunities within Universal Health CareSudarsan Mandal, Ashish Bhat
BMJ Open|August 29, 2022
Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant/non-responsive multidrug-resistant pulmonary tuberculosis: study protocolChandrasekaran Padmapriyadarsini, Bella Devaleenal, C Ponnuraja, et al.
BMJ Open|July 28, 2022
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020Kathiresan Jeyashree, Jeromie Thangaraj, Kiran Rade, et al.
Pageof 1